The potential of [18F]FDG-Tz as a pretargetedPET agent was further confirmed in a pretargeted experiment with TCO-functionalizedMSNA against HER2 in HCC1954 tumor-bearing mice. The gene discussed is ERBB2; the disease is neoplasm.